Published in J Physiol Pharmacol on December 01, 2005
Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. Physiol Rev (2014) 1.57
Distinct regulation of stearoyl-CoA desaturase 1 gene expression by cis and trans C18:1 fatty acids in human aortic smooth muscle cells. Genes Nutr (2011) 0.83
Trans fatty acids exacerbate dextran sodium sulphate-induced colitis by promoting the up-regulation of macrophage-derived proinflammatory cytokines involved in T helper 17 cell polarization. Clin Exp Immunol (2013) 0.82
Imaging and shape analysis of GUVs as model plasma membranes: effect of trans DOPC on membrane properties. Biophys J (2007) 0.76
A trans10-18:1 enriched fraction from beef fed a barley grain-based diet induces lipogenic gene expression and reduces viability of HepG2 cells. Biochem Biophys Rep (2016) 0.75
A novel mechanism by which probucol lowers low density lipoprotein levels demonstrated in the LDL receptor-deficient rabbit. J Lipid Res (1984) 1.22
Rapid quantification of human ABCA1 mRNA in various cell types and tissues by real-time reverse transcription-PCR. Clin Chem (2001) 1.02
Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages. Biochim Biophys Acta (1993) 1.01
Simvastatin modulates TNFalpha-induced adhesion molecules expression in human endothelial cells. Life Sci (2004) 0.96
Decrease in fibrinogen and LDL-cholesterol levels upon supplementation of diet with Lactobacillus plantarum in subjects with moderately elevated cholesterol. Atherosclerosis (1998) 0.96
Effects of novel plant antioxidants on platelet superoxide production and aggregation in atherosclerosis. J Physiol Pharmacol (2006) 0.92
Leptin receptor isoforms expressed in human adipose tissue. Metabolism (1998) 0.91
Is abnormal postprandial lipemia a familial risk factor for coronary artery disease in individuals with normal fasting concentrations of triglycerides and cholesterol? Coron Artery Dis (2000) 0.87
Propionate reduces the cytokine-induced VCAM-1 and ICAM-1 expression by inhibiting nuclear factor-kappa B (NF-kappaB) activation. J Physiol Pharmacol (2009) 0.86
Oenothera paradoxa defatted seeds extract containing pentagalloylglucose and procyanidins potentiates the cytotoxicity of vincristine. J Physiol Pharmacol (2010) 0.84
Selective inhibition by probucol of vascular cell adhesion molecule-1 (VCAM-1) expression in human vascular endothelial cells. Atherosclerosis (2001) 0.81
Increased levels of factor VII, fibrinogen and activity of plasminogen activator inhibitor during postprandial triglyceridemia in patients with ischemic heart disease confirmed by angiography. Nutr Metab Cardiovasc Dis (1999) 0.80
Ibuprofen inhibits adhesiveness of monocytes to endothelium and reduces cellular oxidative stress in smokers and non-smokers. Eur J Clin Invest (2000) 0.79
Selective inhibition by alpha-tocopherol of vascular cell adhesion molecule-1 expression in human vascular endothelial cells. Biochem Biophys Res Commun (2000) 0.79
A pleiotropic antiatherogenic action of ibuprofen. Med Sci Monit (2001) 0.79
The effect of short-term and prolonged fructose intake on VLDL-TG and relative properties on apo CIII1 and apo CII in the VLDL fraction in type IV hyperlipoproteinaemia. Nahrung (1982) 0.77
Von Willebrand factor, fibrinogen and other risk factors of thrombosis in patients with a history of cerebrovascular ischemic stroke and their children. Nutr Metab Cardiovasc Dis (2002) 0.77
Ibuprofen protects low density lipoproteins against oxidative modification. Life Sci (1999) 0.77
The effect of thermally oxidized soya bean oil on metabolism of chylomicrons. Increased uptake and degradation of oxidized chylomicrons in cultured mouse macrophages. Atherosclerosis (1987) 0.76
Optimized RT-PCR method for assaying expression of monocyte chemotactic protein type 1 (MCP-1) in rabbit aorta. Biochem Genet (2006) 0.76
LDL-R and Apo-B-100 gene mutations in Polish familial hypercholesterolemias. Hum Genet (1998) 0.76
From the history of investigations on the oxidative modification of small dense LDL. Atherosclerosis (1998) 0.75
[Reduction of the plasma LDL-cholesterol level among young healthy men as a result of the change from butter to soft margarine in the unbalanced diet]. Pol Arch Med Wewn (2001) 0.75
[Cholesterol, triglyceride and apolipoprotein concentrations in the serum and lipoprotein fractions in the first trimester of normal pregnancy and threatened abortion]. Ginekol Pol (1984) 0.75
Apolipoproteins C in very low density lipoproteins (VLDL) in idiopathic hyperlipoproteinaemia. Acta Physiol Pol (1983) 0.75
[Fibrinogen (Fb) concentrations in patients with ischaemic heart disease undergoing coronary angiography]. Pol Arch Med Wewn (2001) 0.75
[Reaction between low density lipoproteins and cultured fibroblasts in a case of familial hypercholesterolemia]. Pol Arch Med Wewn (1983) 0.75
Serum triglycerides, cholesterol, low density lipoprotein-apo B and high density lipoprotein cholesterol subfractions after moderate body weight loss. Nahrung (1984) 0.75
Effects of perindopril treatment on hemostatic function in patients with essential hypertension in relation to angiotensin converting enzyme (ACE) and plasminogen activator inhibitor-1 (PAI-1) gene polymorphisms. Nutr Metab Cardiovasc Dis (2004) 0.75
Very low density lipoprotein (VLDL) pattern in primary hyperlipoproteinaemia type IIb and type IV. Mater Med Pol (1980) 0.75
Lp(a), homocysteine and a family history of early ischemic cerebral stroke. Nutr Metab Cardiovasc Dis (2001) 0.75
The influence of clofibrate on lipid and protein components of very low density lipoproteins in type IV hyperlipoproteinaemia. Atherosclerosis (1980) 0.75
[Apolipoproteins - an important diagnostic indicator in the evaluation of coronary disease risk]. Pol Arch Med Wewn (1980) 0.75
[Effect of dietetic recommendations on the level of some lipid and hemostatic parameters in offspring of parents with risk factors for coronary heart disease]. Pol Arch Med Wewn (1996) 0.75
Etofibrate decreases factor VII and fibrinogen levels in patients with polymetabolic syndrome. Int J Clin Pharmacol Res (1999) 0.75
[Scintigraphic investigations with 57Co-bleomycin and 67Ga-citrate in patients with malignant lymphomas (author's transl)]. Pol Przegl Radiol Med Nukl (1982) 0.75
[Incidence of hyperlipidemia among male population aged 40-59 years from Warsaw industrial plants]. Pol Arch Med Wewn (1980) 0.75
Receptor-mediated uptake of hypertriglyceridaemic VLDL remnants by mouse macrophages in vitro. Nahrung (1985) 0.75
[Macrophages in the pathogenesis of atherosclerosis. Advances in science and personal observations]. Kardiol Pol (1989) 0.75
[Isoelectric focusing of apolipoproteins E in the VLDL lipoprotein fraction in the diagnosis of type III lipoproteinemia]. Pol Arch Med Wewn (1983) 0.75
Propranolol decreases cholesteryl ester accumulation in mouse peritoneal macrophage in vitro. Mater Med Pol (1990) 0.75
[Homocysteine: a risk factor for atherosclerosis]. Neurol Neurochir Pol (2001) 0.75
Lipoprotein fractions in idiopathic hyperlipoproteinaemia. Acta Physiol Pol (1983) 0.75
[Assessment of the level of B and C apolipoproteins in very low density lipoproteins (VLDL) in normolipemic subjects]. Pol Arch Med Wewn (1979) 0.75
Fibrinogen, factor VII, antithrombin III, cholesterol and triglycerides in young men with myocardial infarction and in their sons. Mater Med Pol (1999) 0.75
[New theories on the role of chylomicrons (alimentary lipemia) in the etiopathogenesis of arteriosclerosis]. Kardiol Pol (1987) 0.75
[Evaluation of lipoprotein (a) and fibrinogen levels in men after premature myocardial infarction and in their sons]. Pol Arch Med Wewn (1996) 0.75
Influence of bezafibrate and colestipol on LDL-cholesterol, LDL-apolipoprotein B and HDL-cholesterol in hyperlipoproteinaemia. Atherosclerosis (1987) 0.75
Influence of experimental diets on cholesterol and triglyceride levels of rabbit blood serum lipoproteins. Acta Physiol Pol (1989) 0.75
[Effect of bezafibrate on lipid and apoprotein levels in patients with idiopathic hypertriglyceridemia]. Kardiol Pol (1982) 0.75
[Phenotyping of secondary hyperlipoproteinemia in diabetics]. Pol Tyg Lek (1974) 0.75
Influence of probucol on enhanced LDL oxidation after fish oil treatment of hypertriglyceridemic patients. Arterioscler Thromb (1993) 0.75
The influence of a no-sugar diet on the composition of VLDL-fraction in patients with idiopathic hyperlipoprotenemia of type IIb and IV. Mater Med Pol (1980) 0.75
[Endogenic hypertriglyceridemia and arteriosclerosis in the light of experimental studies]. Przegl Lek (1982) 0.75